Purchase Order HHSN302201600193P
Award Date 8/17/16
Potential Completion Date 12/23/20
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Human Genome Research Institute awarded a purchase order to Qiagen, LLC for $10,456.60 on August 16, 2016, with firm fixed price, no set-aside. Place of performance is Bethesda, Maryland. The order calls for molecular diagnostics consumables and reagents, including DNA/RNA extraction kits and related laboratory supplies. Ultimate completion date is December 22, 2020.</p>
- The National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services, awarded a $14,896.00 firm fixed-price purchase order to Qiagen, LLC for HGMD DOWNLOAD, RESEARCH USE, LAB services. The contract has an ultimate completion date of November 30, 2024 and was awarded on December 1, 2023. This award does not utilize a set-aside designation. Qiagen, LLC is a division of the international biotechnology company Qiagen N.V. and has provided various...
- <p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation for $4,427.49 on December 1, 2017, with ultimate completion by December 31, 2018. No set-aside was applied. Place of performance is Bethesda, Maryland. The order procures scientific supplies or equipment typical of Life Technologies' federal portfolio, which includes laboratory instrumentation, reagents, and consumables for genomic research applications.</p>
- <p>The National Institutes of Health Clinical Center issued a purchase order to Qiagen, LLC on August 4, 2017, for $12,830.65 under firm fixed price terms, with performance completion by August 10, 2017. Work is performed at Bethesda, Maryland. The order procures molecular diagnostics products and supplies, which are part of Qiagen's standard federal portfolio of DNA/RNA extraction kits, reagents, and laboratory consumables supporting biomedical research and clinical diagnostic operations.</p>
- <p>The National Human Genome Research Institute issued a $122,145.01 delivery order to Illumina, Inc. on September 15, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order has a firm fixed-price structure with an ultimate completion date of December 15, 2017. No set-aside was used.</p>
- <p>The National Human Genome Research Institute issued a $149,618.50 delivery order to Illumina, Inc., on September 1, 2017, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order has a firm fixed-price structure with an ultimate completion date of September 30, 2017.</p>
- <p>The National Human Genome Research Institute issued a $105,412.33 delivery order to Illumina, Inc. on September 14, 2017, for genetic sequencing and genomic analysis equipment and consumables.</p> <p>Place of performance is North Bethesda, MD. The order is firm fixed price with an ultimate completion date of January 31, 2018. No set-aside was used.</p>
- This is a $31,481 firm-fixed-price BPA call contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency under the U.S. Department of Health and Human Services (HHS), to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. The contract has an ultimate completion date of April 30, 2017 and does not utilize a set-aside designation. Qiagen is a manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions,...
- <p>The National Human Genome Research Institute issued a $5,450.23 delivery order to Illumina, Inc. on August 15, 2018, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is North Bethesda, MD. The order carries a firm fixed-price structure and an ultimate completion date of September 14, 2018.</p>
- <p>The National Human Genome Research Institute issued a $24,926.45 delivery order to Illumina, Inc. on September 19, 2019, under a firm fixed-price structure.</p> <p>Place of performance is Bethesda, MD. The order was due for completion on September 2, 2020. No set-aside was applied to this delivery order.</p>
The National Human Genome Research Institute issued a purchase order to Qiagen, LLC on August 17, 2016, for $4,285.40 under a firm fixed-price arrangement. Performance is located in Bethesda, Maryland, with an ultimate completion date of December 23, 2020. No set-aside was applied to this order. The source does not specify the particular products or services procured under this purchase order.
Generated 6/1/26, 10:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($256) | 12/23/20 | |
| Not listed | Not listed | $4.5k | 8/16/16 |